Cannara Biotech

Cannara Biotech Inventory

The Inventory of Cannara Biotech (LOVE.V) as of Oct 19, 2026 is 51.33 M CAD. In the previous year, Inventory was 40.07 M CAD — a change of 28.10% (higher).

Inventory

51.33 MCAD

YoY

28.10%

Last updated:

Inventory of Cannara Biotech is 2025 51.33 M CAD. Inventory of Cannara Biotech was 2024 40.07 M CAD. It decreases by 28.10% higher compared to the previous year.

The Cannara Biotech Inventory history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Inventory
Date
Inventory
Jan 1, 2019
186,707.00 CAD
Jan 1, 2020
2.24 M CAD
Jan 1, 2021
7.41 M CAD
Jan 1, 2022
18.98 M CAD
Jan 1, 2023
33.77 M CAD
Jan 1, 2024
40.07 M CAD
Jan 1, 2025
51.33 M CAD
The Cannara Biotech Inventory history
YEARInventoryYoY
51.33 MCAD+28.10%
40.07 MCAD+18.66%
33.77 MCAD+77.94%
18.98 MCAD+156.12%
7.41 MCAD+230.57%
2.24 MCAD+1,100.66%
186,707.00CAD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cannara Biotech Stock analysis

What does Cannara Biotech do? Cannara Biotech Inc., based in Vancouver, Canada, operates in the Health Care sector, specifically within Pharmaceuticals. The company produces premium cannabis and cannabis-derivative products through its subsidiaries Cannara Biotech (Quebec) Inc. and Cannara Biotech (Valleyfield) Inc. It manages two large facilities in Quebec covering over 1,650,000 square feet, enabling an annual cultivation output of 100,000 kilograms. Cannara Biotech operates in two segments: Cannabis operations, involving cultivation, processing, and sales of dried cannabis and derivatives for the Canadian market, and Real estate operations related to its Farnham and Valleyfield properties. Its brand portfolio includes Tribal, Nugz, and Orchid CBD, a wellness brand offering CBD-dominant products. Cannara Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cannara Biotech stock

Inventory of Cannara Biotech is 51.33 M CAD in 2025.

Inventory of Cannara Biotech changed from 40.07 M CAD to 51.33 M CAD, representing a 28.10% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Inventory Cannara Biotech since 2006 – with annual values, charts, and detailed analysis.

Inventory includes raw materials, work-in-progress, and finished goods. Efficient inventory management is crucial for profitability.

Inventory's CAD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Inventory's Cannara Biotech historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Cannara Biotech

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Cannara Biotech